CTOs on the Move

Biometrica Systems Inc

www.biometrica.com

 
Biometrica Systems Inc is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Las Vegas, NV. To find more information about Biometrica Systems Inc, please visit www.biometrica.com
  • Number of Employees: 0-25
  • Annual Revenue: $10-50 Million
  • www.biometrica.com
  • 750 E Warm Springs Rd Ste 240
    Las Vegas, NV USA 89119-4383
  • Phone: 702.870.6949

Executives

Name Title Contact Details

Similar Companies

BHealth

BHealth is a Mountain View, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Honor Care

Honor is changing the way we care for our parents. Founded in 2014, the San Francisco–based company brings workforce management and technology expertise together with high-touch, personalized care to improve the in-home care experience. Since launching the Honor Care Network in 2017, Honor has partnered with a growing roster of independently owned home care agencies to deliver reliable, transparent, and high-quality care. The Honor Care Network currently provides non-medical home care services to families in more than 800 cities and towns across the United States.

Busse Hospital Disposables

Busse Hospital Disposables is a Hauppauge, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

South Florida Baptist Hospital

South Florida Baptist Hospital, Inc is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. South Florida Baptist Hospital, Inc is based in Plant City, FL. You can find more information on South Florida Baptist Hospital, Inc at www.sjbhealth.org

ProKidney

ProKidney, a pioneer in the treatment of chronic kidney disease (CKD) through innovations in cellular therapy, was founded in 2015 after a decade of research. ProKidney`s lead product candidate, REACT® (Renal Autologous Cell Therapy), is a first-of-its-kind, patented disease-modifying autologous cellular therapy with the potential to not only slow and stabilize the progression of CKD, but in some cases drive meaningful improvement in kidney function. REACT® has received Regenerative Medicine Advanced Therapy (RMAT) designation, as well as FDA and EMA guidance, supporting an immediate start to a global registrational program, which launched in the United States on schedule in January 2022. On January 18, 2022, ProKidney announced that it would become a publicly traded company via a business combination with Social Capital Suvretta Holdings Corp. III